AJANTA PHARMA

BSE: 532331 02 Oct 2025

Healthcare

₹ 2401

Ajanta Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

AJANTA PHARMA

BSE: 532331 02 Oct 2025

Healthcare

₹ 2401

Ajanta Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

303.0

Dividend Yield

1.14%

Debt to Equity

0.01

Stock P/E

33.1

Market Cap

30,799 Cr

AJANTA PHARMA - Share Price & Details

Market Cap

₹30,799

High /Low

3,464 / 2,022

Stock P/E

33.1

Book Value

₹303.0

Dividend Yield

1.14

ROCE

32.4

ROE

₹24.9

Face Value

2.0

PEG Ratio

3.8

EVEBITDA

₹22.3

Debt

47.4

CMP / FCF

43.9

Debt to equity

₹0.01

NP Ann

920

High price all time

3,486

Piotroski score

₹6.0

Graham Number

713.0

No. Eq. Shares

12.5

Net CF

₹47.3

Net profit

930

Price to book value

8.12

Interest Coverage

₹48.4

Low price all time

4.03

Industry PE

33.0

Reserves

₹3,765

Free Cash Flow

₹840

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
19 Sep 2025	Prabhudas Lilladher	Buy	₹2,545.8	₹3,200	26%	moneycontrol	View
30 May 2025	Motilal Oswal	Buy	₹2,700.85	₹3,260	20.4%	moneycontrol	View
07 May 2025	ICICI Securities	Sell	₹2,590.3	₹2,500	-3.3%	moneycontrol	View
30 Jan 2025	Motilal Oswal	Buy	₹2,676.05	₹3,220	18.4%	moneycontrol	View
28 Oct 2024	Motilal Oswal	Buy	₹2,921.1	₹3,470	15.8%	moneycontrol	View
30 Jul 2024	Motilal Oswal	Buy	₹2,522.75	₹2,935	-1.1%	moneycontrol	View
03 May 2024	Motilal Oswal	Buy	₹2,377	₹2,565	-13.5%	moneycontrol	View
31 Jan 2024	Motilal Oswal	Buy	₹2,170.05	₹2,515	-15.2%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	NA	NA	NA	NA	0
AJANTA PHARMA LTD.	12491.9	2549.7	12085.6	20.4	30,799	33.1
Krishna Institute of Medical S	3856.0	588.0	3734.0	1.47	29078	78.8
Dr. Lal Pathlabs Limited	6670.0	1293.0	6407.0	15.49	26762	52.2

Peer Comparison Chart

About AJANTA PHARMA

Ajanta Pharma Ltd., with Security Code 532331, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

Ajanta Pharma Promoter Ravi Agrawal Releases Pledge on 1.3 Lakh Shares

(11 Sep 2025)

Ravi Agrawal, a promoter of Ajanta Pharma Limited, has released a pledge on 1,30,000 shares, equivalent to 0.10% of the total share capital.

Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Latest Stock Performance Being Led By Its Strong Fundamentals?

(08 Sep 2025)

Most readers would already know that Ajanta Pharma's (NSE:AJANTPHARM) stock increased by 3.7% over the past week. Given...

Quarterly Table

Standalone Consolidated

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	848.9	1,014.6	945.2	1,085.3	926.1	1,077.3	1,128.9	1,101.9	1,013.9	1,208.6
Expenses	704.3	737.7	671.5	758.1	698.9	761.4	826.0	765.6	764.3	879.2
Operating Profit	144.5	276.9	273.7	327.2	227.2	315.8	302.9	336.3	249.7	329.4
OPM %	17.03%	27.29%	28.95%	30.15%	24.53%	29.32%	26.83%	30.52%	24.62%	27.26%
Other Income	36.8	31.5	52.2	13.7	33.7	28.4	40.3	33.2	17.9	40.6
Interest	1.2	0.8	2.3	2.4	1.4	0.7	0.7	2.5	0.7	0.7
Depreciation	32.1	32.2	33.0	33.4	33.5	32.9	33.3	34.9	38.8	40.3
Profit before tax	148.0	275.4	290.5	305.1	225.9	310.6	309.2	332.2	228.2	329.0
Tax %	-20.8%	-23%	-26.9%	-27.9%	-28%	-24%	-24%	-24%	-15.2%	22.5%
Net Profit	117.2	212.0	212.4	220.2	162.7	236.0	235.0	252.5	193.4	255.0
EPS in Rs	9.15	16.84	16.85	17.47	12.91	18.75	18.74	20.15	0	20.4

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	971.8	881.8	1,021.0	1,028.4	1,105.2	1,054.1	1,144.9	1,186.6	1,146.1	1,170.4
Expenses	802.2	732.5	749.7	737.8	791.1	775.8	814.6	875.5	825.3	873.3
Operating Profit	169.6	149.4	271.3	290.7	314.1	278.3	330.4	311.2	320.8	297.2
OPM %	17.45%	16.94%	26.57%	28.26%	28.42%	26.4%	28.85%	26.22%	27.99%	25.39%
Other Income	34.9	36.8	31.8	21.3	13.6	35.5	26.5	19.5	30.4	18.1
Interest	2.8	1.1	0.9	2.3	2.5	1.5	0.7	6.0	7.9	6.1
Depreciation	33.3	33.0	33.2	33.7	34.3	34.3	34.0	34.4	36.0	39.8
Profit before tax	168.3	152.1	269.0	275.9	290.9	278.0	322.1	290.2	307.4	269.4
Tax %	-20.1%	-19.6%	-22.6%	-29.2%	-27.8%	-27.1%	-23.7%	-25.4%	-24.2%	-16.4%
Net Profit	134.5	122.3	208.1	195.3	210.0	202.7	245.8	216.5	232.9	225.3
EPS in Rs	10.5	9.54	16.53	15.5	16.67	16.09	19.53	17.26	18.59	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	12%
5 Years:	15%
3 Years:	11%
TTM:	9%

Compounded Profit Growth
10 Years:	11%
5 Years:	16%
3 Years:	8%
TTM:	15%

Stock Price CAGR
10 Years:	10%
5 Years:	21%
3 Years:	31%
1 Year:	7%

Compounded Sales Growth
10 Years:	12%
5 Years:	12%
3 Years:	12%
TTM:	10%

Compounded Profit Growth
10 Years:	11%
5 Years:	14%
3 Years:	9%
TTM:	14%

Stock Price CAGR
10 Years:	10%
5 Years:	21%
3 Years:	31%
1 Year:	7%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

AJANTA PHARMA

AJANTA PHARMA

AJANTA PHARMA - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About AJANTA PHARMA

Order Book

Latest News

Ajanta Pharma Promoter Ravi Agrawal Releases Pledge on 1.3 Lakh Shares

Is Ajanta Pharma Limited's (NSE:AJANTPHARM) Latest Stock Performance Being Led By Its Strong Fundamentals?

Ajanta Pharma Ltd up for third straight session

Ajanta Pharma Ltd drops for fifth straight session

Ajanta Pharma confirms IT Department search; says process still underway

Ajanta Pharma says Income Tax search ongoing at offices, units

Ajanta Pharma allots 23 525 equity shares under ESOP

Stock market update: Nifty Pharma index advances 0.42%

Ajanta Pharma Ltd. - Negative Breakout: 8 stocks cross below their 200 DMAs

Sumitomo Chemicals, Ajanta Pharma our technical analysis picks

Ajanta Pharma reports Q1 FY26 consolidated PAT at Rs. 255.34 Cr

ajanta pharma revenue grows around 14 percent yoy to rs 1303 crore

Ajanta Pharma Limited (NSE:AJANTPHARM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Ajanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside

Stock Picks: Sagar Doshi suggests Jindal Steel, Ajanta Pharma, Godrej Agrovet shares to buy today - 30 July

Technical Analysis: Ajanta Pharma Limited (532331) - Explosive wealth accumulation

Stock market update: Nifty Pharma index falls 0.27%

Ajanta Pharma Ltd spurts 0.96%, up for five straight sessions

Ajanta Pharma Ltd spurts 1.6%, gains for third straight session

Ajanta Pharma's (NSE:AJANTPHARM) five-year earnings growth trails the stellar shareholder returns

Ajanta Pharma Promoter Pledges 2.6 Lakh Shares for Lender Change

With 42% ownership, Ajanta Pharma Limited (NSE:AJANTPHARM) insiders have a lot at stake

Stock market update: Nifty Pharma index advances 0.3% in an upbeat market

Stock market update: Nifty Pharma index advances 0.08%

Stock market update: Nifty Pharma index falls 0.68%

Stock market update: Nifty Pharma index advances 0.92%

Ajanta Pharma elevates Prafull Bhandari to Senior Vice President - PPIC

Stock market update: Nifty Pharma index advances 1.22%

Ajanta Pharma Q4 Review: Revenue Inline But Margins Contract- Systematix Maintains Buy, Cuts Target Price

Buy Ajanta Pharma; Target Price Revised

Ajanta Pharma Ltd Share Price Today, AJANTPHARM Share Price NSE, BSE

Ajanta Pharma Q4 Results: Revenue, margins miss estimates as Africa business weighs

Top 10 Pharmaceutical Companies in India in 2025

Ajanta Pharma Limited (NSE:AJANTPHARM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Ajanta Pharma Positioned For Steady Growth; Jefferies Initiates Coverage With Buy

Trump Reciprocal Tariffs: These Pharma stocks now have the highest upside potential

Top 10 Pharma Companies in India 2025

Ajanta Pharma May See 12% Upside As India Growth Outlook Remains Robust: Axis Capital

Piramal Pharma Ltd Spurts 3.8%

What Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E Is Not Telling You

Ajanta Pharma Shows Resilience Amid Broader Market Declines in February 2025

Ajanta Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Ajanta Pharma Faces Challenges Amid Broader Pharmaceuticals Sector Volatility

Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Stock market update: Nifty Pharma index 1.04%

Ajanta Pharma Stock Declines 3.77% on January 13, 2025, Underperforming Sector

Stock market update: Nifty Pharma index 1.31% in a weak market

Ajanta Pharma Ltd. Sees Revision in Stock Evaluation Amid Market Fluctuations in Q1 2025

Pfizer, Minda Corp, Ajanta Pharma: Brokerage picks 5 stocks for short-term gain; note down targets

Ajanta Pharma Stock Rises 3.06%, Outperforming Sector Amid Positive Market Sentiment

Ajanta Pharma Stock Rises 3.93% After Five-Day Decline, Outperforming Sector

Ajanta Pharma Surges 3.93%, Outperforming Sector Amid Recent Declines

Ajanta Pharma Ltd slips for fifth straight session

Stock market update: Nifty Pharma index 0.31%

Stock market update: Nifty Pharma index 1.01% in a weak market

Stock market update: Nifty Pharma index 0.44%

Torrent Pharma Share Price Today Live NSE/BSE -Torrent Pharmaceuticals Ltd. Stock Price, Key Insights and Summary

Stock market update: Nifty Pharma index 0.33%

Ajanta Pharma Reports 3.19% Stock Gain on December 16, 2024

Stock market update: Nifty Pharma index falls 0.84% in a weak market

Stock market update: Nifty Pharma index 0.4% in an upbeat market

Stock market update: Nifty Pharma index 0.05%

Stock market update: Nifty Pharma index 0.69% in a weak market

Stock market update: Nifty Pharma index 0.46%

Stock market update: Nifty Pharma index falls 0.33% in a weak market

Ajanta Pharma Ltd soars 1.25%, up for fifth straight session

Ajanta Pharma Ltd gains for third straight session

Ajanta Pharma Ltd down for fifth straight session

Ajanta Pharma Limited (NSE:AJANTPHARM) Is About To Go Ex-Dividend, And It Pays A 1.8% Yield